NORTH READING, Mass., Nov. 9, 2016 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for
"As the only track and trace solution provider with a network-tenant platform, TraceLink has a unique advantage to see industry trends and supply chain complexities across more than 244,000 trading partners on our Life Sciences Cloud," said Shabbir Dahod, president and CEO, TraceLink. "This study, which is the first annual report of its kind, sheds light on the current challenges that the industry faced in addressing U.S. lot-level compliance, and highlights how these learnings will likely impact the industry's ability to meet the DSCSA serialization deadline. While the majority of industry may think it's ready for serialization, the results disclose critical indicators that will motivate those who may have been delaying serialization implementation decisions to take action now."
The December 13 webinar titled, "Global Drug Supply, Safety & Traceability Report: Using 2015 Lot-Level Learnings to Understand Future Serialization Challenges," will reveal survey results from 331 respondents across the pharmaceutical supply chain (30% pharmaceutical and contract manufacturers, 14% wholesale distributors, 45% hospitals and 11% retail pharmacies.)
TraceLink partnered with independent research firm, Actionable Research, to conduct the study, gathering industry insights and experience with DSCSA lot-level implementation, including business trading habits; system modifications and investments made to achieve compliance; overall serialization readiness throughout every segment of the supply chain; and potential vulnerabilities to patient safety. The report discloses key findings on how the industry managed lot-level implementation, revealing a fragmented approach and ambiguity across all segments of the supply chain, including:
The live webinar, "Global Drug Supply, Safety & Traceability Report: Using 2015 Lot-Level Learnings to Understand Future Serialization Challenges," will be held at 10 a.m. ET on Tuesday, December 13, 2016, hosted by Shabbir Dahod, president and CEO of TraceLink. An analyst from Actionable Research will also be available during a live Q&A with webinar attendees.
To register for the webinar, use this link. The event will also be recorded and available for on-demand viewing at www.tracelink.com.
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations.
A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost.
For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by FirstMark Capital, Volition Capital and F-Prime Capital.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tracelink-to-host-live-webinar-on-results-from-industrys-first-global-drug-supply-safety-and-traceability-report-300359765.html
SOURCE TraceLink Inc.
Subscribe to our Free Newsletters!
Discover the amazing health benefits of this ''under-valued'' vegetable called leek. Know the ...
Dehydration occurs when there is depletion of body fluids without adequate replacement. Test your ...
Cardiopulmonary bypass is a technique which allows performing open heart surgical procedures in a ...View All